MICS Centrum Medyczne Torun
- Address
- ul. Stefana Batorego 18-22, 87-100 Torun, Poland
MICS Centrum Medyczne Torun - Oncology and Immunology Research Center
MICS Centrum Medyczne Torun is a distinguished clinical research facility specializing in advanced oncology and immunology therapeutic investigations. The center demonstrates particular expertise in conducting complex, multi-phase trials for patients with challenging hematologic malignancies and solid tumors, as well as autoimmune conditions requiring innovative treatment approaches.
- Metastatic castration-resistant prostate cancer studies evaluating novel epigenetic modulators and hormonal therapy combinations
- Relapsed and refractory hematologic malignancies including multiple myeloma and acute myeloid leukemia with targeted molecular therapies
- Autoimmune and inflammatory conditions, particularly active psoriatic arthritis with biologic and small molecule disease-modifying agents
The center's research portfolio reflects a commitment to precision medicine, particularly in biomarker-driven oncology trials involving patients with specific genetic mutations such as NPM1-mutated and KMT2A-rearranged leukemias. MICS Centrum Medyczne Torun participates in both early-phase dose-finding studies and pivotal efficacy trials, supporting the development of next-generation targeted therapies for patients with limited treatment options, including those with relapsed or refractory disease who have exhausted standard therapeutic approaches.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 36 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MICS Centrum Medyczne Torun
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of Efficacy of Subcutaneous Abatacept Versus Adalimumab on Methotrexate in Early Seropositive Rheumatoid Arthritis with HLA Class II Risk Alleles | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | Nov 2021 | — |
IMP list
lock Showing 1 of 36 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apremilast | 2 | Unknown | 2021-10-29 | 2025-06-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.